SRRA stock forecast
Our latest prediction for Sierra Oncology, Inc.'s stock price was made on the Feb. 14, 2017 when the stock price was at 1.40$.
In the short term (2weeks), SRRA's stock price should outperform the market by 6.61%. During that period the price should oscillate between -7.16% and +13.77%.
In the medium term (3months), SRRA's stock price should outperform the market by 12.79%. During that period the price should oscillate between -15.91% and +42.14%.Get email alerts
About Sierra Oncology, Inc.
Sierra Oncology, Inc. is a clinical stage drug development company of therapeutics for the treatment of patients with cancer. It engages in the business of researching, developing, and commercializing therapies for the treatment of patients with cancer. The company was founded on May 8, 2003 and is headquartered in Vancouver, Canada.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.77$ per share.
The book value per share is 1.62$
Three months stock forecastFeb. 14, 2017
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|